The growing cohort of seniors with HIV/AIDS: changing the scope of Medicare Part D

AIDS Care
Paul J FlaerJai Parkash

Abstract

HIV/AIDS medications are generally expensive and government assistance is often necessary to limit high out-of-pocket patient costs. Lowered patient out-of-pocket costs were the objective of government involvement in drug provision through legislation creating Medicare Part D. However, the Medicare program faces a surge in those beneficiaries living longer on more effective antiretroviral drugs. Higher prevalence of HIV/AIDS patients means more opportunity for transmission of the infection and recidivistic behavior such as non-adherence to medication regimens. Along with the resulting increased frequency of opportunistic infections in HIV/AIDS patients comes the requirement for aggressive pharmacological treatment. To meet this need, Medicare Part D provides drugs for the treatment of opportunistic infections occurring in HIV/AIDS patients. Problematically, though, Medicare Part D contains so many choices that it tends to overwhelm patients and sometimes even the providers and insurance companies as well. The multiplicity of choices in this highly complex program for the aged and infirm often leads to confusion and incorrect choices by beneficiaries. Furthermore, the advent of tiered cost-sharing or formulary management by Medi...Continue Reading

References

Apr 25, 2000·Journal of Gerontological Nursing·T A Szirony
May 17, 2000·Journal of Midwifery & Women's Health·R Lieberman
Aug 4, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Joel V Brill
Feb 5, 2008·Journal of Managed Care Pharmacy : JMCP·Ronnie Depue, Joann Stubbings
Aug 6, 2008·Advances in Skin & Wound Care·Kathleen D Schaum
Mar 24, 2009·Lancet·Peter PiotJulian Lob-Levyt
Apr 16, 2009·Current Infectious Disease Reports·Kelly A Gebo, Amy Justice
Jun 18, 2009·Current Opinion in HIV and AIDS·Frances Cowan, Audrey Pettifor

❮ Previous
Next ❯

Citations

Sep 9, 2011·The Journal of the Association of Nurses in AIDS Care : JANAC·Nancy C Sharts-Hopko

❮ Previous
Next ❯

Related Concepts

Related Feeds

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.